Charles Bouaziz appointed Chief Executive Officer of MTD

Lugano, 20th September 2022 – Medical Technology and Devices appointed Charles Bouaziz as new Chief Executive Officer of the Group. Charles is an industry veteran with more than 30 years of experience in consumer and healthcare and joins from Ontex Group NV, a Belgium-based producer of disposable personal hygiene solutions.

Mr. Bouaziz has a strong track record of delivering significant transformation and solid growth in the companies he has previously managed, driven by both organic expansion such as entering new regions, opening new distribution channels (including digital / e-commerce), or developing and launching new products, as well as non-organic developments such as selected M&A deals aiming at accelerating business evolution while delivering strategic synergies.

Mr. Bouaziz graduated from the École Supérieure des Sciences Economiques et Commerciales (ESSEC Grande École). He gained an outstanding international experience managing consumer and consumer-health businesses having spent 4 years at Procter & Gamble France, and then over 20 years leading different business units at PepsiCo both in France and across Europe. More recently, Mr. Bouaziz built a successful track record in private-equity backed companies.

Mr. Bouaziz, upon his appointment, said: “I’m thrilled to join MTD, an evolving and dynamic group, a leader in the expanding medical devices space with a strong brand portfolio such as the well-known PIC (broadly recognized for consumer-health excellence, particularly in Italy and Southern Europe) and Droplet that is expanding at a quick pace in US gaining growing trust from consumers and diabetes patients in North America.”

Antonio Gatti, Board Member of MTD stated: “We are proud to welcome a manager such as Charles who is bringing an outstanding international experience and a clear track-record of business transformation and expansion. We believe Charles will significantly contribute to the future MTD developments leveraging his experience which blends corporate expertise, investor mindset and M&A capabilities.

We would sincerely like to thank Micol Fornaroli who successfully led MTD through the combination of HTL and Pikdare, the operational improvement started in 2019 and the very positive performance delivered in the last 3 years. Under Micol leadership, the company developed new businesses, enlarged its market presence and successfully secured hospitals, health care professionals and patients during the difficult Covid-19 crisis. Micol decided to start a new journey in the life science, and we wish her success for her new professional adventure.”